Indeed, the inactivation of Kindlin-2 in MDA-MB-231 cells, using the CRISPR/Cas9 technology, induced a drastic inhibition of tumor formation, cell invasion and lung metastasis, suggesting that Kindlin-1 is not able to compensate for the loss of Kindlin-2 in these conditions. The gene discussed is FERMT1; the disease is neoplasm.